Cboe BZX
01:45:08 2024-04-25 pm EDT
5-day change
1st Jan Change
89.54
USD
-0.73%
-1.12%
-5.51%
The Cooper Companies, Inc.(NYSE:COO) dropped from Russell 1000 Growth-Defensive Index
June 25, 2021 at 12:00 am EDT
The Cooper Companies, Inc.(NYSE:COO) dropped from Russell 1000 Growth-Defensive Index
Citigroup Raises Price Target on Cooper Companies to $116 From $108, Keeps Buy Rating
Apr. 03
MT
Cooper Companies Insider Sold Shares Worth $5,521,230, According to a Recent SEC Filing
Mar. 21
MT
North American Morning Briefing : Markets on Hold -2-
Mar. 20
DJ
All eyes on the Fed
Mar. 19
ANALYST RECOMMENDATIONS : 3M Company, Snowflake, Splunk, Micron, Nvidia...
Mar. 19
Redburn Atlantic Upgrades Cooper Companies to Buy From Neutral, Adjusts Price Target to $125 From $93.75
Mar. 19
MT
Not a care in the world
Mar. 13
JPMorgan Upgrades Cooper Companies to Overweight From Neutral, Adjusts Price Target to $120 From $100
Mar. 13
MT
ANALYST RECOMMENDATIONS : Broadcom, Tesla, Walmart, Entain, Virgin Money UK
Mar. 13
Cooper Companies Insider Sold Shares Worth $24,659,342, According to a Recent SEC Filing
Mar. 11
MT
Piper Sandler Adjusts Price Target on Cooper to $115 From $110, Maintains Overweight Rating
Mar. 01
MT
Cooper to Benefit From Strong Contacts Market as Demand Continues, Morgan Stanley Says
Mar. 01
MT
Mizuho Adjusts Price Target on Cooper to $115 From $102.50, Maintains Buy Rating
Mar. 01
MT
Morgan Stanley Lifts Price Target on Cooper Cos. to $95 From $88.75 After Better-Than-Expected Fiscal Q1; Equalweight Kept
Mar. 01
MT
Cooper Companies lifts annual revenue forecast on strong contact lens demand
Feb. 29
RE
Transcript : The Cooper Companies, Inc., Q1 2024 Earnings Call, Feb 29, 2024
Feb. 29
Cooper Fiscal Q1 Non-GAAP EPS, Net Sales Increase; Issues Outlook
Feb. 29
MT
The Cooper Companies, Inc. Raises its Revenue Guidance for the Fiscal Year 2024
Feb. 29
CI
The Cooper Companies, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
Feb. 29
CI
Cooper Companies Guides For FY 2024 EPS of $3.50-$3.58 on Revenue of $3.847-$3.897 Billion, vs CIQ Analyst Consensus of $3.46/Share on Revenue of $3.86 Billion
Feb. 29
MT
Earnings Flash (COO) COOPERCOMPANIES Posts Q1 Revenue $931.6M, vs. Street Est of $917.5M
Feb. 29
MT
Earnings Flash (COO) COOPERCOMPANIES Reports Q1 EPS $0.85, vs. Street Est of $0.78
Feb. 29
MT
Just as expected
Feb. 29
ANALYST RECOMMENDATIONS : Amex, Snowflake, Salesforce, Walmart, Nutrien...
Feb. 29
The calm after the storm
Feb. 28
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
More about the company
Last Close Price
90.2
USD
Average target price
107.9
USD
Spread / Average Target
+19.63%
Consensus
1st Jan change
Capi.
-5.51% 17.93B +11.01% 98.89B +9.02% 39.29B -21.74% 2.14B -10.96% 1.55B +31.15% 1.16B -35.29% 744M -36.77% 730M -13.18% 636M +24.44% 477M
Glasses, Spectacles & Contact Lenses
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
THE COOPER COMPANIES, INC. 
